| Lactose (India) Ltd | 146 Cr. | 116 | 247/84.3 | 32.3 | 49.6 | 0.00 % | 12.9 % | 9.69 % | 10.0 |
| MPS Pharmaa Ltd | 3.36 Cr. | 1.76 | 4.33/1.76 | | 0.33 | 0.00 % | 9.79 % | 59.0 % | 10.0 |
| Gujarat Themis Biosyn Ltd | 4,112 Cr. | 377 | 479/192 | 85.2 | 24.3 | 0.18 % | 27.3 % | 21.7 % | 1.00 |
| Gujarat Terce Laboratories Ltd | 35.5 Cr. | 47.9 | 92.2/37.2 | | 10.6 | 0.00 % | 41.4 % | 14.6 % | 10.0 |
| Gujarat Inject (Kerala) Ltd | 44.0 Cr. | 30.0 | 30.5/17.0 | 105 | 6.93 | 0.00 % | 13.5 % | 11.0 % | 10.0 |
| Godavari Drugs Ltd | 55.0 Cr. | 73.1 | 134/72.1 | 14.9 | 60.3 | 0.00 % | 10.1 % | 10.6 % | 10.0 |
| Glenmark Life Sciences Ltd | 55,543 Cr. | 1,968 | 2,286/1,275 | 22.1 | 340 | 0.13 % | 19.4 % | 15.8 % | 1.00 |
| Gennex Laboratories Ltd | 328 Cr. | 13.5 | 19.0/10.8 | 19.7 | 8.79 | 0.00 % | 13.0 % | 10.2 % | 1.00 |
| Ganga Pharmaceuticals Ltd | 6.90 Cr. | 11.7 | 19.2/9.25 | 86.2 | 14.0 | 0.00 % | 3.18 % | 1.13 % | 10.0 |
| Fredun Pharmaceuticals Ltd | 885 Cr. | 1,874 | 1,999/635 | 30.6 | 334 | 0.04 % | 18.9 % | 15.8 % | 10.0 |
| Fervent Synergies Ltd | 92.6 Cr. | 18.5 | 32.0/17.1 | 25.3 | 10.8 | 0.00 % | 7.47 % | 7.47 % | 10.0 |
| Fermenta Biotech Ltd | 792 Cr. | 269 | 449/219 | 7.07 | 133 | 0.93 % | 23.0 % | 24.9 % | 5.00 |
| Fabino Enterprises Ltd | 4.83 Cr. | 23.0 | 39.0/22.8 | | 19.2 | 0.00 % | 7.16 % | 3.08 % | 10.0 |
| Evoq Remedies Ltd | 7.20 Cr. | 2.89 | 9.28/2.11 | 4.09 | 17.9 | 0.00 % | 0.35 % | 0.26 % | 10.0 |
| Everest Organics Ltd | 424 Cr. | 437 | 477/152 | 64.1 | 74.7 | 0.00 % | 1.76 % | 2.23 % | 10.0 |
| Entero Healthcare Solutions Ltd | 4,498 Cr. | 1,034 | 1,565/1,022 | 40.7 | 406 | 0.00 % | 8.71 % | 5.63 % | 10.0 |
| Murae Organisor Ltd | 55.2 Cr. | 0.27 | 1.12/0.26 | 3.63 | 1.02 | 0.00 % | 4.20 % | 5.69 % | 1.00 |
| Dipna Pharmachem Ltd | 38.1 Cr. | 14.5 | 26.3/7.10 | 18.6 | 24.5 | 0.00 % | 6.64 % | 2.55 % | 10.0 |
| Decipher Labs Ltd | 9.85 Cr. | 9.76 | 17.2/9.00 | | 19.0 | 0.00 % | 4.67 % | 1.16 % | 10.0 |
| Coral Laboratories Ltd | 161 Cr. | 452 | 859/443 | 9.12 | 596 | 0.33 % | 17.4 % | 13.1 % | 10.0 |
| Concord Drugs Ltd | 73.0 Cr. | 73.0 | 92.5/26.1 | 138 | 34.4 | 0.00 % | 4.73 % | 0.88 % | 10.0 |
| Concord Biotech Ltd | 14,233 Cr. | 1,360 | 2,452/1,345 | 44.2 | 174 | 0.76 % | 28.4 % | 21.4 % | 1.00 |
| Colinz Laboratories Ltd | 20.1 Cr. | 44.0 | 88.7/36.1 | 43.7 | 21.6 | 0.00 % | 6.72 % | 5.43 % | 10.0 |
| Cian Healthcare Ltd | 13.8 Cr. | 5.51 | 7.66/2.97 | | 13.0 | 0.00 % | 10.6 % | 30.3 % | 10.0 |
| Chemo Pharma Laboratories Ltd | 15.9 Cr. | 106 | 154/63.0 | | 9.60 | 0.00 % | 5.17 % | 3.47 % | 10.0 |
| Checkpoint Trends Ltd | 61.1 Cr. | 112 | 112/9.41 | 42.2 | 3.60 | 0.00 % | 16.5 % | 9.17 % | 10.0 |
| Chandra Bhagat Pharma Ltd | 28.5 Cr. | 37.8 | 80.0/33.0 | 46.0 | 40.3 | 0.00 % | 6.00 % | 2.41 % | 10.0 |
| Brawn Biotech Ltd | 6.03 Cr. | 20.1 | 26.0/15.5 | | 12.3 | 0.00 % | 42.5 % | 41.3 % | 10.0 |
| Blue Jet Healthcare Ltd | 9,487 Cr. | 547 | 1,028/492 | 27.0 | 72.4 | 0.22 % | 39.8 % | 30.2 % | 2.00 |
| Bharat Immunological & Biological Corporation Ltd | 79.8 Cr. | 18.5 | 35.9/18.0 | | 18.2 | 0.00 % | 9.27 % | 17.7 % | 10.0 |
| Beryl Drugs Ltd | 10.7 Cr. | 21.0 | 43.7/17.4 | 46.4 | 18.6 | 0.00 % | 10.2 % | 6.30 % | 10.0 |
| Mankind Pharma Ltd | 90,219 Cr. | 2,186 | 3,055/2,115 | 54.2 | 376 | 0.05 % | 15.0 % | 13.9 % | 1.00 |
| BDH Industries Ltd | 210 Cr. | 365 | 524/241 | 21.6 | 123 | 1.23 % | 17.8 % | 14.2 % | 10.0 |
| Bacil Pharma Ltd | 58.8 Cr. | 41.0 | 62.6/26.7 | 91.9 | 18.4 | 0.00 % | 0.97 % | 0.98 % | 10.0 |
| Aurobindo Pharma Ltd | 68,395 Cr. | 1,178 | 1,365/994 | 20.0 | 603 | 0.33 % | 14.2 % | 11.1 % | 1.00 |
| Auro Laboratories Ltd | 149 Cr. | 239 | 303/159 | 142 | 69.9 | 0.00 % | 3.85 % | 4.33 % | 10.0 |
| Anuh Pharma Ltd | 797 Cr. | 79.5 | 123/74.0 | 20.6 | 32.6 | 1.88 % | 17.2 % | 13.4 % | 5.00 |
| ANG Lifesciences India Ltd | 38.8 Cr. | 29.7 | 49.7/21.0 | | 50.0 | 0.00 % | 3.54 % | 13.8 % | 10.0 |
| Acutaas Chemicals Ltd | 13,505 Cr. | 1,650 | 1,902/919 | 60.4 | 173 | 0.09 % | 19.9 % | 16.0 % | 5.00 |
| Amerise Biosciences Ltd | 4.04 Cr. | 0.61 | 1.45/0.55 | 101 | 0.81 | 0.00 % | 0.19 % | 0.19 % | 1.00 |
| Ambalal Sarabhai Enterprises Ltd | 203 Cr. | 26.5 | 68.0/26.0 | 13.0 | 19.2 | 0.00 % | 9.12 % | 6.25 % | 10.0 |
| Adline Chem Lab Ltd | 4.45 Cr. | 7.60 | 22.2/7.60 | | 2.75 | 0.00 % | % | % | 10.0 |
| Achyut Healthcare Ltd | 133 Cr. | 5.64 | 6.57/2.82 | 309 | 1.34 | 0.00 % | 2.26 % | 1.77 % | 1.00 |
| Abbott India Ltd | 61,127 Cr. | 28,766 | 37,000/25,260 | 40.5 | 1,888 | 1.65 % | 46.2 % | 35.7 % | 10.0 |
| Aarti Pharmalabs Ltd | 6,390 Cr. | 705 | 972/550 | 26.7 | 226 | 0.69 % | 17.4 % | 14.5 % | 5.00 |
| Aarey Drugs & Pharmaceuticals Ltd | 206 Cr. | 72.6 | 100/31.3 | 57.5 | 52.5 | 0.00 % | 6.38 % | 2.96 % | 10.0 |
| Zota Health Care Ltd | 4,875 Cr. | 1,591 | 1,740/606 | | 103 | 0.06 % | 17.0 % | 36.0 % | 10.0 |
| Wockhardt Ltd | 21,265 Cr. | 1,309 | 1,870/1,110 | 388 | 281 | 0.00 % | 3.75 % | 1.22 % | 5.00 |
| Wanbury Ltd | 818 Cr. | 234 | 330/154 | 19.0 | 18.1 | 0.00 % | 36.7 % | 76.5 % | 10.0 |
| Vivimed Labs Ltd | 41.0 Cr. | 4.95 | / | | 5.79 | 0.00 % | 8.10 % | % | 2.00 |
| Venus Remedies Ltd | 1,023 Cr. | 765 | 808/270 | 16.2 | 445 | 0.00 % | 11.1 % | 7.16 % | 10.0 |
| Unichem Laboratories Ltd | 3,091 Cr. | 439 | 839/438 | 21.2 | 346 | 0.00 % | 6.24 % | 5.59 % | 2.00 |
| TTK Healthcare Ltd | 1,501 Cr. | 1,062 | 1,595/991 | 21.2 | 768 | 0.94 % | 9.26 % | 6.89 % | 10.0 |
| Torrent Pharmaceuticals Ltd | 1,27,299 Cr. | 3,761 | 3,882/2,886 | 58.8 | 250 | 0.85 % | 27.0 % | 26.5 % | 5.00 |
| Themis Medicare Ltd | 933 Cr. | 101 | 296/98.0 | | 41.3 | 0.47 % | 10.4 % | 7.65 % | 1.00 |
| Syncom Formulations (India) Ltd | 1,401 Cr. | 14.9 | 24.0/14.1 | 22.3 | 4.00 | 0.00 % | 18.6 % | 15.5 % | 1.00 |
| Cohance Lifesciences Ltd | 20,330 Cr. | 531 | 1,342/525 | 59.2 | 99.0 | 0.00 % | 14.9 % | 12.7 % | 1.00 |
| Suven Life Sciences Ltd | 3,767 Cr. | 166 | 303/102 | | 12.4 | 0.00 % | 87.0 % | 87.2 % | 1.00 |
| Sun Pharmaceuticals Industries Ltd | 4,31,496 Cr. | 1,798 | 1,910/1,547 | 37.4 | 324 | 0.89 % | 20.2 % | 16.9 % | 1.00 |
| Solara Active Pharma Sciences Ltd | 2,424 Cr. | 550 | 791/441 | 378 | 347 | 0.00 % | 6.01 % | 0.05 % | 10.0 |
| SMS Pharmaceuticals Ltd | 3,003 Cr. | 321 | 335/175 | 37.0 | 81.2 | 0.13 % | 12.2 % | 11.0 % | 1.00 |
| SMS Lifesciences India Ltd | 357 Cr. | 1,197 | 1,680/956 | 20.6 | 650 | 0.13 % | 11.8 % | 10.8 % | 10.0 |
| Shilpa Medicare Ltd | 6,356 Cr. | 325 | 502/265 | 41.1 | 125 | 0.15 % | 7.82 % | 4.21 % | 1.00 |
| Sequent Scientific Ltd | 4,959 Cr. | 196 | 260/111 | 115 | 32.2 | 0.00 % | 8.47 % | 3.21 % | 2.00 |
| Sanofi India Ltd | 9,836 Cr. | 4,271 | 6,718/4,146 | 26.6 | 340 | 2.70 % | 49.2 % | 47.2 % | 10.0 |
| RPG Life Sciences Ltd | 3,685 Cr. | 2,228 | 2,725/1,772 | 33.1 | 335 | 0.91 % | 32.8 % | 25.5 % | 8.00 |
| Procter & Gamble Health Ltd | 9,397 Cr. | 5,661 | 6,739/4,904 | 30.6 | 373 | 2.23 % | 47.8 % | 36.4 % | 10.0 |
| Pharmaids Pharmaceuticals Ltd | 185 Cr. | 52.5 | 85.0/42.0 | | 14.7 | 0.00 % | 17.4 % | 16.3 % | 10.0 |
| Pfizer Ltd | 22,700 Cr. | 4,962 | 5,993/3,701 | 32.1 | 841 | 0.70 % | 21.6 % | 16.4 % | 10.0 |
| Par Drugs & Chemicals Ltd | 124 Cr. | 101 | 237/81.0 | 12.8 | 86.5 | 0.00 % | 18.4 % | 13.6 % | 10.0 |
| Panacea Biotec Ltd | 2,001 Cr. | 327 | 582/281 | | 135 | 0.00 % | 4.57 % | 4.92 % | 1.00 |
| Ortin Laboratories Ltd | 16.4 Cr. | 20.1 | 26.4/16.2 | | 3.47 | 0.00 % | 60.2 % | 118 % | 10.0 |
| Orchid Pharma Ltd | 4,211 Cr. | 830 | 1,998/604 | 80.6 | 251 | 0.00 % | 8.07 % | 8.21 % | 10.0 |
| Neuland Laboratories Ltd | 20,682 Cr. | 16,120 | 19,748/10,060 | 106 | 1,263 | 0.07 % | 18.7 % | 14.8 % | 10.0 |
| Nectar Lifescience Ltd | 457 Cr. | 20.4 | 44.9/13.0 | | 32.0 | 0.00 % | 5.36 % | 11.2 % | 1.00 |
| Natco Pharma Ltd | 16,129 Cr. | 900 | 1,505/660 | 10.5 | 483 | 0.64 % | 32.8 % | 28.0 % | 2.00 |
| Morepen Laboratories Ltd | 2,236 Cr. | 40.8 | 91.7/40.6 | 29.6 | 21.8 | 0.47 % | 15.1 % | 11.8 % | 2.00 |
| Marksans Pharma Ltd | 8,322 Cr. | 184 | 347/162 | 23.7 | 59.3 | 0.43 % | 20.0 % | 16.8 % | 1.00 |
| Mangalam Drugs and Organics Ltd | 38.9 Cr. | 24.6 | 130/23.9 | | 80.5 | 0.00 % | 8.03 % | 4.71 % | 10.0 |
| Lyka Labs Ltd | 266 Cr. | 74.5 | 177/74.2 | 130 | 28.3 | 0.00 % | 9.91 % | 9.31 % | 10.0 |
| Lupin Ltd | 94,273 Cr. | 2,064 | 2,403/1,774 | 21.8 | 430 | 0.57 % | 21.3 % | 20.6 % | 2.00 |
| Lincoln Pharmaceuticals Ltd | 959 Cr. | 479 | 980/478 | 12.0 | 357 | 0.37 % | 17.3 % | 12.8 % | 10.0 |
| Laurus Labs Ltd | 54,091 Cr. | 1,002 | 1,040/501 | 79.2 | 91.1 | 0.12 % | 9.47 % | 7.75 % | 2.00 |
| Kwality Pharmaceuticals Ltd | 902 Cr. | 869 | 1,235/596 | 18.4 | 281 | 0.00 % | 18.2 % | 16.2 % | 10.0 |
| Krebs Biochemicals & Industries Ltd | 146 Cr. | 67.5 | 116/63.6 | | 73.2 | 0.00 % | 30.1 % | % | 10.0 |
| Kopran Ltd | 628 Cr. | 130 | 227/123 | 35.6 | 104 | 2.32 % | 9.75 % | 7.64 % | 10.0 |
| Kilitch Drugs (India) Ltd | 565 Cr. | 323 | 500/265 | 20.5 | 152 | 0.00 % | 15.7 % | 12.6 % | 10.0 |
| Jubilant Pharmova Ltd | 16,570 Cr. | 1,040 | 1,250/802 | 33.4 | 414 | 0.47 % | 9.54 % | 9.55 % | 1.00 |
| J B Chemicals & Pharmaceuticals Ltd | 28,318 Cr. | 1,808 | 1,952/1,303 | 39.4 | 243 | 0.84 % | 25.8 % | 20.1 % | 1.00 |
| Jagsonpal Pharmaceuticals Ltd | 1,325 Cr. | 198 | 302/193 | 30.3 | 38.0 | 1.27 % | 23.0 % | 18.6 % | 2.00 |
| Ipca Laboratories Ltd | 36,764 Cr. | 1,449 | 1,758/1,168 | 37.1 | 293 | 0.27 % | 14.7 % | 12.8 % | 1.00 |
| IOL Chemicals & Pharmaceuticals Ltd | 2,383 Cr. | 81.2 | 127/57.5 | 20.5 | 59.7 | 0.97 % | 8.86 % | 6.13 % | 2.00 |
| Ind-Swift Ltd | 85.4 Cr. | 15.8 | 34.7/12.0 | 10.9 | 74.2 | 0.00 % | 11.9 % | % | 2.00 |
| Ind-Swift Laboratories Ltd | 743 Cr. | 91.0 | 124/67.2 | 25.1 | 160 | 0.00 % | 0.78 % | 0.18 % | 10.0 |
| Indoco Remedies Ltd | 2,334 Cr. | 253 | 350/190 | | 106 | 0.08 % | 0.49 % | 7.02 % | 2.00 |
| Hikal Ltd | 2,885 Cr. | 234 | 457/217 | 286 | 96.9 | 0.60 % | 9.85 % | 7.38 % | 2.00 |
| Hester Biosciences Ltd | 1,349 Cr. | 1,585 | 2,576/1,243 | 30.7 | 397 | 0.43 % | 9.71 % | 9.18 % | 10.0 |
| Gufic BioSciences Ltd | 3,482 Cr. | 347 | 498/285 | 64.1 | 62.7 | 0.03 % | 13.2 % | 12.3 % | 1.00 |
| Granules India Ltd | 13,211 Cr. | 544 | 621/412 | 25.8 | 164 | 0.27 % | 15.1 % | 13.9 % | 1.00 |
| Glenmark Pharmaceuticals Ltd | 54,228 Cr. | 1,922 | 2,286/1,275 | 21.5 | 340 | 0.13 % | 19.4 % | 15.8 % | 1.00 |
| Glaxosmithkline Pharmaceuticals Ltd | 42,812 Cr. | 2,527 | 3,516/1,921 | 44.9 | 101 | 1.65 % | 63.2 % | 46.9 % | 10.0 |
| Gland Pharma Ltd | 27,998 Cr. | 1,699 | 2,131/1,200 | 24.2 | 610 | 1.04 % | 15.8 % | 11.6 % | 1.00 |
| FDC Ltd | 6,737 Cr. | 414 | 528/359 | 29.9 | 149 | 1.20 % | 15.9 % | 11.8 % | 1.00 |
| ERIS Lifesciences Ltd | 20,836 Cr. | 1,530 | 1,910/1,097 | 50.1 | 227 | 0.47 % | 12.2 % | 12.9 % | 1.00 |
| Dr Reddys Laboratories Ltd | 1,05,838 Cr. | 1,268 | 1,406/1,020 | 18.4 | 432 | 0.63 % | 22.7 % | 18.0 % | 1.00 |
| Dishman Carbogen Amcis Ltd | 3,408 Cr. | 217 | 322/178 | 22.8 | 406 | 0.00 % | 2.42 % | 0.32 % | 2.00 |
| Cipla Ltd | 1,21,537 Cr. | 1,505 | 1,673/1,310 | 22.4 | 408 | 0.85 % | 22.7 % | 17.8 % | 2.00 |
| Caplin Point Laboratories Ltd | 14,561 Cr. | 1,916 | 2,641/1,551 | 24.7 | 416 | 0.31 % | 25.8 % | 22.7 % | 2.00 |
| Brooks Laboratories Ltd | 282 Cr. | 95.9 | 203/95.2 | 20.2 | 39.3 | 0.00 % | 9.93 % | 12.2 % | 10.0 |
| Bliss GVS Pharma Ltd | 1,699 Cr. | 161 | 191/105 | 15.6 | 107 | 0.29 % | 11.7 % | 8.36 % | 1.00 |
| Biofil Chemicals & Pharmaceuticals Ltd | 55.5 Cr. | 34.1 | 67.7/32.6 | 19.5 | 13.1 | 0.00 % | 4.12 % | 3.03 % | 10.0 |
| Biocon Ltd | 51,567 Cr. | 386 | 425/291 | 109 | 200 | 0.13 % | 6.25 % | 4.76 % | 5.00 |
| Beta Drugs Ltd | 1,633 Cr. | 1,618 | 2,190/1,430 | 36.1 | 219 | 0.00 % | 27.0 % | 25.9 % | 10.0 |
| Bal Pharma Ltd | 114 Cr. | 71.5 | 132/70.0 | 16.7 | 49.2 | 1.68 % | 10.1 % | 9.66 % | 10.0 |
| Bafna Pharmaceuticals Ltd | 346 Cr. | 146 | 205/67.8 | 32.8 | 38.6 | 0.00 % | 8.34 % | 7.69 % | 10.0 |
| Astrazeneca Pharma India Ltd | 22,649 Cr. | 9,060 | 10,691/6,301 | 98.0 | 320 | 0.35 % | 33.4 % | 23.6 % | 2.00 |
| Amrutanjan Health Care Ltd | 1,867 Cr. | 646 | 843/544 | 32.9 | 118 | 0.70 % | 22.4 % | 16.5 % | 1.00 |
| Alpa Laboratories Ltd | 168 Cr. | 79.8 | 137/75.2 | 8.92 | 92.0 | 0.00 % | 15.0 % | 11.5 % | 10.0 |
| Alkem Laboratories Ltd | 67,120 Cr. | 5,614 | 5,868/4,492 | 28.6 | 1,116 | 0.79 % | 20.4 % | 19.4 % | 2.00 |
| Alembic Pharmaceuticals Ltd | 17,298 Cr. | 880 | 1,124/725 | 27.3 | 271 | 1.22 % | 13.0 % | 11.4 % | 2.00 |
| Albert David Ltd | 432 Cr. | 757 | 1,540/757 | | 690 | 0.65 % | 6.45 % | 4.39 % | 10.0 |
| Ajanta Pharma Ltd | 33,366 Cr. | 2,671 | 3,116/2,022 | 34.3 | 345 | 1.06 % | 32.4 % | 24.9 % | 2.00 |
| Advanced Enzyme Technologies Ltd | 3,414 Cr. | 305 | 412/258 | 23.2 | 133 | 1.76 % | 13.1 % | 9.54 % | 2.00 |
| Aarti Drugs Limited | 3,634 Cr. | 398 | 575/312 | 19.1 | 147 | 0.25 % | 13.5 % | 13.0 % | 10.0 |
| Industry Average | 20,332.04 Cr | 1,154.48 | | 51.34 | 202.18 | 0.36% | 16.29% | 15.20% | 6.10 |